US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 27.750
  • -1.310-4.51%
Close Nov 11 16:00 ET
  • 27.750
  • 0.0000.00%
Post 16:01 ET
821.32MMarket Cap-12144P/E (TTM)

Dianthus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dianthus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 595.330K --
-- 2024/Q4 -- / 610.780K --
-- 2024/Q3 2.172M / 576.440K --
-- 2024/Q2 1.863M / 322.750K --
-- 2024/Q1 874.000K / 371.400K --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 595.330K--
--2024/Q4-- / 610.780K--
--2024/Q32.172M / 576.440K--
--2024/Q21.863M / 322.750K--
--2024/Q1874.000K / 371.400K--

Unlock Free Earnings Estimates

Dianthus Therapeutics Earnings Reports

  • Dianthus Therapeutics | 10-Q: Quarterly report

    Nov 8 05:10

  • Dianthus Therapeutics | 10-Q: Quarterly report

    Aug 9 04:16

  • Dianthus Therapeutics | 10-Q: Quarterly report

    May 10 04:53

  • Dianthus Therapeutics | 10-K: FY2023 Annual Report

    Mar 22 04:14

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 11, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data